Avantor raises FY revenue growth, profit guidance after Q3 beat
AVTR•Avantor reported Q3 sales of $1.70 billion and adjusted EPS of $0.22, beating analyst estimates, and raised its FY 2026 organic revenue growth, adjusted EPS and free cash flow guidance.
1. Q3 results beat estimates
Avantor's Q3 sales rose 4.6% to $1.70 billion, above the $1.64 billion analyst consensus. Adjusted EPS was $0.22, compared with the $0.21 estimate.
2. Full-year guidance raised
Avantor raised its FY 2026 organic revenue growth outlook to 0.75% to 1.25%, from negative 0.5% to positive 0.5%. It increased adjusted EPS guidance to $0.81-$0.83 from $0.80-$0.83 and lifted its free cash flow forecast to $525 million-$550 million from $500 million-$550 million.
3. Business performance
VWR Distribution & Services organic growth accelerated to 5.8%, while Bioscience & Medtech Products returned to organic growth as expected. The company attributed results to sharpened strategic focus and improved execution.
